CME Group Inc. $CME Stock Acquired by Miller Howard Investments Inc. NY

Miller Howard Investments Inc. NY boosted its stake in shares of CME Group Inc. (NASDAQ:CME) by 20.8% during the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 192,542 shares of the financial services provider’s stock after buying an additional 33,169 shares during the period. Miller Howard Investments Inc. NY’s holdings in CME Group were worth $50,442,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of CME. Brookmont Capital Management increased its position in shares of CME Group by 0.6% during the third quarter. Brookmont Capital Management now owns 5,661 shares of the financial services provider’s stock worth $1,483,000 after acquiring an additional 34 shares in the last quarter. Manchester Capital Management LLC raised its holdings in shares of CME Group by 2.9% during the third quarter. Manchester Capital Management LLC now owns 1,297 shares of the financial services provider’s stock worth $340,000 after acquiring an additional 37 shares during the period. NBT Bank N A NY raised its holdings in shares of CME Group by 2.3% during the first quarter. NBT Bank N A NY now owns 1,666 shares of the financial services provider’s stock worth $492,000 after acquiring an additional 38 shares during the period. Resonant Capital Advisors LLC lifted its position in CME Group by 3.8% in the 1st quarter. Resonant Capital Advisors LLC now owns 1,073 shares of the financial services provider’s stock valued at $317,000 after acquiring an additional 39 shares in the last quarter. Finally, Grove Bank & Trust lifted its position in CME Group by 0.8% in the 3rd quarter. Grove Bank & Trust now owns 5,038 shares of the financial services provider’s stock valued at $1,320,000 after acquiring an additional 39 shares in the last quarter. Institutional investors own 87.75% of the company’s stock.

CME Group Price Performance

Shares of CME opened at $308.06 on Tuesday. The stock has a market capitalization of $110.77 billion, a P/E ratio of 25.27, a P/E/G ratio of 3.73 and a beta of 0.24. CME Group Inc. has a twelve month low of $218.31 and a twelve month high of $329.16. The company has a 50 day moving average of $277.37 and a 200-day moving average of $279.18. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13.

CME Group (NASDAQ:CME) last announced its quarterly earnings data on Wednesday, October 21st. The financial services provider reported $3.02 EPS for the quarter, topping analysts’ consensus estimates of $2.99 by $0.03. The business had revenue of $1.74 billion for the quarter, compared to analyst estimates of $1.71 billion. CME Group had a net margin of 63.33% and a return on equity of 16.23%. The firm’s revenue for the quarter was up 10.6% on a year-over-year basis. During the same quarter in the previous year, the firm posted $2.68 earnings per share. As a group, equities research analysts forecast that CME Group Inc. will post 12.35 EPS for the current fiscal year.

CME Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, September 25th. Investors of record on Wednesday, September 9th were given a $1.30 dividend. The ex-dividend date of this dividend was Wednesday, September 9th. This represents a $5.20 dividend on an annualized basis and a yield of 1.7%. CME Group’s dividend payout ratio (DPR) is 42.66%.

Wall Street Analysts Forecast Growth

A number of equities analysts recently weighed in on the stock. Wall Street Zen raised shares of CME Group from a “strong sell” rating to a “sell” rating in a research note on Saturday, October 3rd. UBS Group lifted their price target on CME Group from $270.00 to $310.00 and gave the company a “neutral” rating in a research note on Thursday, October 22nd. CLSA set a $367.00 price target on CME Group in a research note on Thursday. Raymond James Financial restated an “outperform” rating and issued a $320.00 price target on shares of CME Group in a report on Thursday, July 2nd. Finally, Morgan Stanley upped their price objective on CME Group from $337.00 to $359.00 and gave the stock an “overweight” rating in a research report on Thursday. Ten investment analysts have rated the stock with a Buy rating, six have given a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat, CME Group has an average rating of “Hold” and an average target price of $313.29.

Insider Buying and Selling at CME Group

In other CME Group news, CEO Terrence Duffy sold 15,000 shares of CME Group stock in a transaction on Thursday, September 10th. The shares were sold at an average price of $274.44, for a total value of $4,116,600.00. Following the sale, the chief executive officer directly owned 40,630 shares in the company, valued at approximately $11,150,497.20. The trade was a 26.96% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director William Shepard purchased 293 shares of the business’s stock in a transaction on Friday, September 25th. The shares were acquired at an average cost of $268.76 per share, for a total transaction of $78,746.68. Following the completion of the transaction, the director directly owned 263,289 shares in the company, valued at approximately $70,761,551.64. This represents a 0.11% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders have sold a total of 15,900 shares of company stock valued at $4,377,655 over the last quarter. 0.30% of the stock is currently owned by corporate insiders.

CME Group Profile

CME Group Inc operates global derivatives marketplaces that provide trading, clearing and settlement services for futures and options contracts. Its products cover major asset classes, including interest rates, equity indexes, foreign currencies, agricultural commodities, energy and metals. The company also provides market data, benchmark information and related services used by financial institutions, corporations, producers, investors and other market participants.

CME Group’s exchange portfolio includes CME, the Chicago Board of Trade, the New York Mercantile Exchange and COMEX.